NWPF

News ArchivesRead News

Another Reason I Can’t POSSIBLY Have Parkinson’s

Thursday February 25, 2010

My Parkinsons' Disease Diary - OK, we already know that caffeine is supposedly neuroprotective and has a role in preventing Parkinson’s disease. I’ve been drinking coffee since I was 14. I have Parkinson’s.

We already know that nicotine is supposedly neuroprotective and has a role in preventing Parkinson’s disease. I’ve been a cigar smoker since I was 17. I have Parkinson’s.

Here’s a NEW reason why I can’t possibly have PD.

People who regularly take the over-the-counter painkiller ibuprofen may have a lower risk of getting Parkinson’s disease, a new study says. Researchers from the Harvard School of Public Health studied more than 136,000 people over six years and asked them about their use of aspirin, ibuprofen and acetaminophen, which are all classified as non-steroid anti-inflammatory drugs, or NSAIDs.

During the study, 293 people developed Parkinson’s disease. That’s 0.2 percent of the people. The researchers said in a news release that ibuprofen were 40 percent less likely to develop Parkinson’s disease than people who didn’t. Also, people who took higher amounts of ibuprofen were less likely to develop Parkinson’s disease than people who took smaller amounts of the drug. The results were the same regardless of age, smoking and caffeine intake, they said.

I’ve been a regular taker of ibuprofen since my late 20s when I first developed arthritis in one of my knees. So, if this is all true…

I can’t POSSIBLY have Parkinson’s disease.

So, what the hell is my neurologist talking about?

Recent News

Jul 24 - Parkinson's: Mutant gene interaction may pave the way for new treatments
Jul 22 - Boxing training used to fight against Parkinson's disease
Jul 17 - Stem cell treatment breakthrough could cure Parkinson’s patients
Jul 14 - Cancer drug shows early promise for Parkinson's disease
Jul 13 - Opinion: Dividing the Caregiving Responsibilities Between Siblings
Jul 12 - Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases
Jul 11 - Parkinson’s Head Trauma Link Looks Even Stronger
Jul 7 - Penn students’ start-up XEED puts wearables to work against Parkinson’s disease
Jul 5 - Last Patient Enrolled in Pivotal Phase 3 Parkinson’s Disease Trial, Cynapsus Therapeutics Says
Jun 29 - Exoskeleton Could Quell the Tremors of Parkinson's Disease Patients at Crucial Moments
Jun 28 - Parkinson's disease: New protein discovery could fuel new treatments
Jun 27 - Study finds direct evidence linking Parkinson’s to autoimmune disease; 2 genes that are key regulators of immune system discovered
Jun 27 - Blocking key enzyme halts parkinson's disease symptoms in mice
Jun 23 - Parkinson's Research Might Benefit from Novel Discovery of Zinc Transport Protein Structure
Jun 23 - Parkinson's disease breakthrough 'could lead to cure'
Jun 20 - More American men diagnosed with Parkinson's
Jun 15 - First monkey genetically engineered to have Parkinson’s created
Jun 14 - Fighting Parkinson's in the lab
Jun 9 - A New Gene Has Been Linked to Parkinson's Disease
Jun 6 - A neurologist weighs in on Muhammad Ali's battle with Parkinson's disease